Cargando…
Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe(3)O(4) nanoparticles
BACKGROUND: Gambogic acid (GA), a potent anticancer agent, is limited in clinical administration due to its poor water solubility. The aim of this study was to explore a drug delivery system based on magnetic Fe(3)O(4) nanoparticles (MNP-Fe(3)O(4)) conjugated with GA to increase water solubility of...
Autores principales: | Wang, Cailian, Zhang, Haijun, Chen, Baoan, Yin, Haitao, Wang, Wenwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173055/ https://www.ncbi.nlm.nih.gov/pubmed/21931488 http://dx.doi.org/10.2147/IJN.S24707 |
Ejemplares similares
-
Gambogic acid-loaded magnetic Fe(3)O(4) nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1
por: Wang, Cailian, et al.
Publicado: (2012) -
Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells
por: Chen, Baoan, et al.
Publicado: (2009) -
Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe(3)O(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells
por: Zhang, Wei, et al.
Publicado: (2015) -
Effects of magnetic nanoparticles of Fe(3)O(4) combinated with gambogic acid on apoptosis of SMMC-7721 cells
por: Tian, Liang, et al.
Publicado: (2015) -
Aminated β-cyclodextrin-grafted Fe(3)O(4)-loaded gambogic acid magnetic nanoparticles: preparation, characterization, and biological evaluation
por: Fang, Wei, et al.
Publicado: (2019)